Avita Medical | 1811094D - Selling And Administration Expenses


Avita Medical reported AUD19.03M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Accuray USD 124.78M 2.54M Dec/2025
Celltrion KRW 12.72B 3.4B Jun/2026
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Kangmei Pharma CNY 253.72M 16.66M Jun/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pacific Edge NZD 16.75M 2.42M Jun/2026
Pharma Mar EUR 17.12M 1.82M Jun/2026
Polynovo AUD 17.04M 1.91M Dec/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Qiagen NV USD 142.33M 60K Jun/2026
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 285.65M 9.96M Mar/2026
Sartorius EUR 216.6M 4.7M Sep/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Telix Pharmaceuticals AUD 107.02M 13.54M Jun/2026
Tilray USD 24.85M 1.7M Sep/2025
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 223.14M 8.82M Jun/2026